Eruptive cutaneous squamous cell carcinoma and psoriasis: Response to cetuximab

M. Kamaria, C. R. Shea, R. K. Chin, E. E. Cohen, R. Maggiore, D. Bolotin

    Research output: Contribution to journalArticle

    6 Scopus citations

    Abstract

    Cutaneous squamous cell carcinomas (CSCCs) comprise 20-30% of nonmelanoma skin cancers (NMSCs), and continue to increase in incidence. We report a case of a patient with severe psoriasis who had recurrent and eruptive CSCCs on her leg, which were successfully treated with cetuximab and radiotherapy. The patient had successful long-term clearance of her skin tumours, with the additional finding of resolution of psoriasis while on cetuximab therapy.

    Original languageEnglish (US)
    Pages (from-to)604-607
    Number of pages4
    JournalClinical and Experimental Dermatology
    Volume39
    Issue number5
    DOIs
    StatePublished - Jul 2014

    ASJC Scopus subject areas

    • Dermatology

    Fingerprint Dive into the research topics of 'Eruptive cutaneous squamous cell carcinoma and psoriasis: Response to cetuximab'. Together they form a unique fingerprint.

  • Cite this

    Kamaria, M., Shea, C. R., Chin, R. K., Cohen, E. E., Maggiore, R., & Bolotin, D. (2014). Eruptive cutaneous squamous cell carcinoma and psoriasis: Response to cetuximab. Clinical and Experimental Dermatology, 39(5), 604-607. https://doi.org/10.1111/ced.12341